skeletal fractures. Thoracic injuries were present in five patients and one patient suffered from a blunt abdominal trauma. Additional demographic and clinical characteristics are presented in Table 1 .
Study Protocol
After evaluation and stabilization of vital parameters in the emergency room, a standard CT scan of the head was obtained. If necessary, intracranial mass lesions were evacuated and additional injuries were treated operatively. Patients were then transferred to the intensive care unit and treated according to the protocol described below.
Management Before Cooling. Conventional intensive care management was followed before applying hypothermia treatment and was maintained unchanged throughout the study period. All patients were deeply sedated and not responsive to pain (Ramsay Scale 51 score of 6). Mean arterial blood pressure (MABP) was adjusted to maintain adequate cerebral perfusion pressure (CPP). 3, 7 The MABP was considered sufficient when its further increase produced no additional decrease in ICP, indicating a CPP within the autoregulatory range, and when the jugular venous oxygen saturation was normal (Ͼ 55%). 7 Adequate intravascular volume was the primary factor for maintaining sufficient MABP. To achieve this we strived for pulmonary artery occlusion pressures above 10 mm Hg and diuresis greater than 2 ml/kg/hour. Vasopressors such as norepinephrine were only used after preceding volume expansion. The hemoglobin concentration was maintained above 90 g/L. Patients with persisting intracranial hypertension (ICP Ͼ 20 mm Hg) were treated with intermittent boluses of mannitol (0.5-1 g/kg). Hyperventilation therapy (PaCO 2 Ͻ 36 mm Hg) was reserved for patients with cerebral hyperemia. Hyperemia was ascertained if global cerebral blood flow (CBF) was elevated (Ͼ 40 ml/100 g/minute) and the cerebral metabolic rate for lactate (CMRL), as a marker for cerebral ischemia, was in the normal range (CMRL Ͻ Ϫ6 mol/100 g/ minute). 53 To prevent false results of hypothermia-related effects on ICP and cerebral metabolism, the precooling dose of methohexital and mannitol remained unchanged during the study. Additionally, the actual CPP and PaCO 2 values of the first measurement series at normothermia were also maintained as well as possible throughout the study period.
Cooling Procedure. Moderate hypothermia was induced as quickly as possible by cooling the body surface with water-circulating blankets placed above and below the patient (Blanketrol II, model 222; Hoyer Medizintechnik, Bremen, Germany). Core temperature was recorded on line using a thermistor-tipped pulmonary artery catheter. To reduce endogenous thermoregulation and to prevent shivering during cooling, patients received a course of methohexital (1.5 mg/kg/hour) and neuromuscular paralysis was induced with administration of vecuronium (0.05 mg/kg/hour). The patient's PaCO 2 was not temperature corrected during hypothermia (␣-stat management).
Times of Measurement.
Before cooling was initiated, the first measurement series was performed to determine baseline values at normothermia. When the desired core temperature of 32.5˚C to 33.0˚C was reached, we conducted the second measurement series (early hypothermia). After approximately 24 hours of sustained hypothermia at 32.5˚C to 33.0˚C, the third measurement series was performed (late hypothermia). Subsequently, patients were slowly rewarmed (approximately 0.2˚C/hour) to a core temperature of 36.5˚C. During the 2 hours after normothermia was reached the fourth measurement series was taken (normothermia after rewarming). For determination of extracerebral effects the study period was extended to 72 hours after rewarming. Supplemental check points were 24 hours and 72 hours after the fourth measurement series.
Applied Monitoring. Depending on the patient's critical illness, invasive hemodynamic monitoring, which included use of an arterial line and a pulmonary artery catheter, was performed. The patient's total body oxygen consumption (VO 2 ) was measured on line using indirect calorimetry (Delta-Trac 100; Fa. Datex Instrumentarium Corp., Helsinki, Finland). Thus inadequate sedation, as well as possible subliminal shivering, could be detected by rising oxygen consumption at a constant body temperature. Intracranial pressure was continuously monitored using an intraparenchymal fiberoptic catheter (OPX-100; Inner Space Medical, Inc., Irvine, CA). Additional bilateral on-line jugular venous oxygen saturation monitoring 1  70, F  fall  4  yes  evac mass lesion  26  5  2  16, F  fall  4  yes  diffuse injury IV  26  5  3  15, M  horse riding accident  3  no  diffuse injury III  26  5  4  27, M  scaffolding accident  3  yes  evac mass lesion  25  1  5  31, M  motor vehicle accident  3  no  evac mass lesion  66  5  6  45, F  motor vehicle accident  6  yes  evac mass lesion  25  5  7  42, M  paragliding accident  3  yes  evac mass lesion  43  1  8  19, M  motor vehicle accident  3  no  evac mass lesion  35  3  9  24, M  motor vehicle accident  3  yes  evac mass lesion  50  5  10 20, M motor vehicle accident 3 no evac mass lesion 35 5 (Oximetrix Abbott Critical Care System, model U 440; Abbott Laboratory, North Chicago, IL) was performed to obtain precise data on cerebral hemodynamics and metabolism. 59 
Data Acquisition
Cerebral Physiological and Metabolic Effects. All CBF measurements were performed in the intensive care unit using the intravenous xenon-133 technique with 10 detectors placed around the patient's head. Cerebral blood flow was estimated according to the CBF15 value using the two-compartment model described by Obrist, et al. 46 The global cerebral metabolic rate for oxygen (CMRO 2 ) was calculated according to Fick as the product of global arteriojugular venous oxygen content difference (AJDO 2 ) and global CBF. 54 Global values of AJDO 2 and CBF were determined as mean values of the right and left hemisphere. Arterial and bilateral jugular venous blood samples were obtained simultaneously with the measurement of CBF for determination of blood gas levels, oxygen saturation, and lactate concentration. Blood gas levels and oxygen saturation were measured immediately with a blood gas analyzer (model 520 ABL; Radiometer, Copenhagen, Denmark). The blood samples for lactate concentration were promptly cooled on ice and analyzed according to an enzymatic method within 20 minutes. 36 For determination of CMRL, we calculated the corresponding values of each hemisphere according to the following formula: CMRL = AJDL ϫ CBF, where AJDL = arteriojugular venous lactate difference. The hemisphere with the highest lactate production was considered as representative.
Extracerebral Effects. Changes in the cardiovascular system were examined by measuring the cardiac index and calculating arterial oxygen delivery (DaO 2 ). Functional changes in the respiratory system were determined using the "Horowitz quotient," which is the ratio of PaO 2 to inspired oxygen (FiO 2 ). Pneumonia was suspected if the following criteria were met: new infiltrates on chest xray films, purulent tracheobronchial secretions, positive bacterial cultures in tracheobronchial secretions, and impairment of pulmonary gas exchange. If only one criterion was missing, a bronchoalveolar lavage was performed. Pneumonia was diagnosed if pathogens could be isolated from the retrieved bronchoalveolar lavage fluid. Renal function was evaluated by urine output and creatinine clearance (C cr ). The activated prothrombin time and the partial thromboplastin time served to judge the intrinsic and extrinsic coagulation pathway. Additionally, platelet counts in arterial blood were determined.
Outcome Assessment. Six months after injury, Glasgow Outcome Scale 29 scores were assigned by an objective physician who was not involved in the study.
Statistical Analysis
For direct comparability between normothermia and moderate hypothermia, the patients served as their own control. For data analysis the Pearson-Stephens test was used to check normal distribution. Because these requirements were not fulfilled, Friedman analysis of variance and the Miller test were performed. A probability of 0.05 or less was regarded as significant.
Results
The time course and individual core temperatures are illustrated in Fig. 1 . The time interval between injury and registration of baseline values at normothermia varied between 6 and 23 hours (median value 16 hours). The time required for cooling to 32.5˚C lasted from 2.3 to 4.5 hours (median value 3 hours). Moderate hypothermia was sustained for 23 to 26 hours (median value 25 hours). The rewarming phase took between 20 and 23.5 hours (median value 22 hours).
Cerebral Physiological and Metabolic Effects
Changes in cerebral physiological and metabolic data are presented in Table 2 . Hypothermia caused a reduction in median CMRO 2 by 45% (early hypothermia). After approximately 24 hours of sustained moderate hypothermia (late hypothermia), we observed a slight increase in median CMRO 2 to a level only 27% below that found prior to cooling. Rewarming led to a further increase in CMRO 2 ; however, the increase remained 15% below the median baseline value. In contrast to CMRO 2 , global CBF did not change significantly during hypothermia. Rewarming was not associated with an increase in CBF.
With respect to precooling CMRL values, we found pathological values less than Ϫ6 mol/100 g/minute in six patients ( Fig. 2 upper left) . At early hypothermia, five of these patients already had normal values of CMRL. The median CMRL was reduced by 72%. After rewarming to 36.5˚C we observed an insignificant increase in CMRL to Ϫ4.6 mol/100 g/minute (Table 2) .
Intracranial hypertension (ICP Ͼ 20 mm Hg) was present at normothermia in six patients despite preceding conventional ICP reduction therapy ( Fig. 2 upper right) . In all patients ICP declined at the early hypothermia stage. At late hypothermia, ICP was below 20 mm Hg in nine patients. During the rewarming phase, one patient showed moderate intracranial rebound hypertension. With respect to median ICP values, hypothermia caused a significant decrease in ICP at early and late hypothermia and at normothermia after rewarming. According to protocol, parameters directly influencing ICP, such as CPP and PaCO 2 , did not change significantly during the study (Table 2) .
Extracerebral Effects
Systemic oxygen consumption (VO 2 ) decreased by 34% from normothermia to early hypothermia. As with CMRO 2 levels, VO 2 also increased during sustained hypothermia ( Table 2 ). The median cardiac index (18%), as well as the median DaO 2 (25%), decreased significantly in the early hypothermia phase. At late hypothermia, both parameters had recovered, and at normothermia after rewarming they even surpassed baseline values (Table 3) . Serious cardiac arrhythmias with cardiovascular instability and severe hypovolemia did not occur. However, during sustained hypothermia up to 24 hours after rewarming there was a statistically insignificant trend toward higher doses of catecholamines required to maintain the preceding baseline levels of CPP (Table 3 ). Pulmonary gas exchange worsened during the study period. The decrease in the median PaO 2 /FiO 2 quotient was statistically significant at late hypothermia and remained significant up to 72 hours after rewarming (Table 3) . Five patients suffered from pneumonia, four of whom were diagnosed toward the end of the rewarming phase.
As far as the coagulation system was concerned, we found no significant changes in the plasma coagulation tests' activated prothrombin time and partial thromboplastic time. In contrast, platelet counts decreased significantly during cooling up to 24 hours after rewarming. At 72 hours after rewarming there was a tendency toward recovery (Table 3) . Bleeding complications were not observed. Diuresis did not change significantly, although there was a trend toward higher urine volumes during hypothermia. Creatinine clearance decreased significantly at late hypothermia and normalized at normothermia by 72 hours after rewarming (Table 3) . The individual C cr values are illustrated in Fig. 2 lower left. Serum Na + concentration increased significantly during cooling but remained in the normal range. Significant changes in serum K + concentrations were not observed (Table 3) . Due to the occurrence of hyperglycemia during hypothermia, two patients required exogenous insulin supplements from late hypothermia up to 24 hours after rewarming. During this period median serum lipase activity rose significantly to a maximum of approximately 470% at late hypothermia (Table  3) . Eight patients had elevated lipase activity during cooling and four patients had marked pathological lipase levels ( Fig. 2 lower right) . At late hypothermia these four patients presented additional signs of acute pancreatitis (pancreatic edema and a small edge of peripancreatic fluid) on ultrasonography and CT. Rewarming was effective in preventing further deterioration. At 24 hours of normothermia serum lipase activity declined and within 2 days it had nearly normalized ( Fig. 2 lower right) . Control studies using ultrasonography and CT revealed complete disappearance of any signs of pancreatitis.
Clinical Outcome
The outcome of patients is shown in Table 1 . Seven of 10 patients returned to their previous occupation (good recovery), one patient survived severely disabled, and two patients died. One of them suffered from multisystemic injury and died from multiorgan system failure. The other had a marked infratentorial trauma and died of brainstem compression on the 7th hospital day.
Discussion
We chose a 24-hour hypothermia period because animal studies have shown that the peak vulnerability of posttraumatic brain ischemia is within the first 24 hours, 28 and a recent clinical study has demonstrated that moderate hypothermia applied for 24 hours is not associated with a higher incidence of complications compared to the control group. 9, 38, 57 
Cerebral Physiological and Metabolic Effects
We collected blood samples for blood gas analysis and lactate concentrations from both jugular bulbs because in head-injured patients marked differences can occur, especially in cases of unilateral lesions. 17 Comparing cerebral venous oxygen saturation of bilateral samples in 32 headinjured patients, Stocchetti, et al., 59 found bilateral differences of more than 15% in 15 patients. The more appropriate side for monitoring could not be identified by CT scan and hemoglobin saturation pattern.
The median baseline CMRO 2 of our patients before cooling was markedly below the normal range. Studies in head-injured patients have shown that the magnitude of metabolic reduction is indicative of the severity of trauma. 47, 52 Other studies demonstrated a relationship between the acute posttraumatic metabolic activity and outcome, which makes the CMRO 2 level a valuable prognostic indicator. 27, 60 According to these findings, all our patients would have had an unfavorable prognosis. Hypothermia reduces the energy requirements of both the activation metabolism for neuronal function and the residual metabolism for maintenance of cellular integrity. 43 In our patient population, induction of hypothermia reduced CMRO 2 by 45% at early hypothermia. Despite no changes in states of sedation, analgesia, and paralysis, we observed a statistically insignificant increase in the calculated CMRO 2 , as well as in the measured VO 2 during sustained hypothermia. It is known that catecholamines may increase oxygen demand. 8, 22, 30 This might explain the rise in VO 2 during cooling. However, the intact blood-brain barrier is impermeable to infused catecholamines. To explain the observed rise in CMRO 2 , which mirrored that of VO 2 for higher catecholamine dosages, the blood-brain barrier would have to have been temporarily disrupted.
The CMRO 2 reduction was caused predominantly by a reduced cerebral oxygen extraction: the median value of global CBF did not change significantly during hypothermia treatment, whereas in contrast, median AJDO 2 decreased significantly by 2.4 ml/100 ml or 44% at early hypothermia. This missing correlation between CBF and CMRO 2 indicates an uncoupling of CBF and metabolism. Marion, et al., 37 found a decline in CBF of approximately 5.2%/1˚C reduction in body temperature in hypothermiatreated patients, compared to patients with normothermia treatment. The absolute CBF values in their hypothermia group, however, showed a nonsignificant increase. In contrast, Shiozaki and coworkers 57 described a hypothermiaassociated mean decrease of 15.4 ml/100 g/minute in absolute CBF and 1.0 ml/100 ml in AJDO 2 in five patients. The most likely explanation for these discrepancies is the
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Moderate hypothermia and severe head injury selection of different time points for inducing hypothermia. The patients reported by Marion, et al., as well as our own were cooled in the early phase after head injury, being characterized by reduced CBF. 4 The secondary increase in CBF following early ischemia may obscure the decrease in absolute CBF during cooling. In Shiozaki and coworkers' study, 57 cooling was initiated in a more advanced phase after head injury when hyperemia was more likely prevalent. 4 Lactate has been shown to accumulate in ischemic brain tissue and to play a role in the pathophysiology of traumatic brain injury. 26, 63, 64 The rate at which lactate moves from brain to venous blood has been a subject of controversy. 10, 48, 65 In rats, shortly after forebrain ischemia was induced, the AJDL was significantly higher than the baseline level. This difference was still significant up to 120 minutes after reperfusion. 16 Robertson and colleagues 53 demonstrated that an increase in CMRL is a prompt and reliable marker of cerebral ischemia in head-injured patients. Normally there is a low but measurable CMRL of Ϫ2.3 mol/100 g/minute. 53 Patients with areas of cerebral infarction on CT scans resulting from prolonged ischemia had markedly elevated lactate production of less than Ϫ6 mol/100 g/minute, whereas patients without cerebral infarction had low CMRL. In our patient population, moderate hypothermia significantly reduced elevated CMRL. This effect persisted even after rewarming the patients. Based on these results, we conclude that moderate hypothermia improves the oxygen supply-demand relationship.
The ICP reduction in our patients corresponds to the results of Marion, et al., 38 and Shiozaki and coworkers. 57 Both teams found a statistically significant decline in ICP in their hypothermia groups. As demonstrated, a decrease in CBF was not a prerequisite for reduction in ICP during hypothermia. The decline in ICP was not accompanied by a statistically significant drop in CBF. Therefore, additional mechanisms must exist to explain the reduction in ICP. At a cellular level hypothermia reduces blood-brain barrier disruption. 11 At a molecular level hypothermia weakens biochemical reactions leading to the accumulation of free radicals. Free radicals damage the membranes of neuronal cells and vessels which leads to brain edema. 5, 6, 21, 34 In summary cerebral edema, not hyperemia, seems to be the major cause of early posttraumatic intracranial hypertension.
4,37

Extracerebral Effects
The knowledge we have about hypothermia-associated effects in humans is largely based on accidental hypothermia. 40 Hypothermia affects virtually every organ system. Primary effects are a generalized slowing of enzymatic activity, peripheral vasoconstriction, and uncoupling of the oxygen-dependent metabolism. 55 Sinus bradycardia is common during hypothermia, but it is often compensated by an increase in stroke volume down to approximately 25˚C. 58 When hypothermia in animals was prolonged up to 24 hours or more, the ejection fraction and cardiac output decreased. 41 Our data show that cardiac performance is not severely affected by moderate hypothermia treatment that lasts up to approximately 24 hours. Only at early hypothermia did the cardiac index decrease significantly (approximately 18%). During rewarming, patients may be vulnerable to hypotension that is caused by peripheral vasodilation. 58 In our patients hypotension was avoided by slow rewarming and pulmonary artery occlusion pressure-guided volume substitution. Mild-to-moderate hypothermia generally is not directly responsible for cardiac dysrhythmias, but may cause conduction disturbances and ventricular irritability by potentiating the effect of drugs or by causing hypokalemia. 2 In our study we did not observe serious cardiac arrhythmias that would lead to cardiovascular instability. Obviously at body temperatures above 32˚C the risk of arrhythmias seems to be low, especially if patients with preexisting cardiac arrhythmias and coronary heart disease are excluded from hypothermia treatment.
Impairment of pulmonary gas exchange, caused by atelectasis in basal alveolar units, is common in trauma patients. 32 In our patients the marked drop in the PaO 2 /FiO 2 ratio after sustained cooling, which was not reversible by rewarming, was at least partially related to atelectasis as demonstrated by daily chest radiography. Furthermore, pneumonia is the most common complication of head injury. 32 The reported indices vary widely from 10% to 80%. 25 In our study, 50% of patients acquired pneumonia within the 1st week of their stay in the intensive care unit. In the early phase of hypothermia, peripheral vasoconstriction leads to increases in central blood volume, renal perfusion, and urine output. 23 If hypothermia is prolonged, a cold diuresis follows, caused by suppression of antidiuretic hormone and reduced tubular enzymatic activity. 56 In this study, urine volume did not change significantly, although there was a trend toward higher diuresis. We assume that cold diuresis was disguised by preexisting polyuria. With respect to the glomerular filtration rate, we found a marked drop in C cr (approximately 60%) at late hypothermia. In accordance with our results, Morales, et al., 44 also reported a reduction in the glomerular filtration rate to approximately 50% of normal at a core temperature of 30˚C in humans. During rewarming, C cr in our patients began to recover and normalized 72 hours later. Therefore, we conclude that the impairment of renal function may be chiefly affected by hypothermia itself.
In our study, serious hypokalemia, resulting from an intracellular shift of potassium, 2 was prevented by careful monitoring of potassium serum concentration and urinary loss. Because of the very slow rewarming (approximately 0.2˚C/hour), rebound hyperkalemia did not occur. Abnormalities in standard coagulation tests and platelet count are common in head trauma patients. 18, 33, 49 The incidence of coagulopathy has been reported to be 24%. 31 Thromboplastin is present in high concentrations in the brain tissue. Its release into the systemic circulation may activate the extrinsic pathway, and disruption of endothelial surfaces may activate the intrinsic pathway. 31 The severity of the coagulation abnormalities correlates well with the severity of the head injury. 49 In this study, precooling coagulation tests, as well as platelet counts, were in the lower range of normal. Hypothermia itself may aggravate clotting abnormalities. 13, 50 Although there are minimal effects on clotting factor levels, hypothermia produces clotting abnormalities functionally equivalent to profound clotting factor deficiency. 20 In our study, we observed no statistically significant prolongation of activated prothrombin time and no decline in partial thromboplastin time occurring at 37˚C. However, temperature-standardized coagulation assays at 37˚C may not accurately reflect the magnitude of clotting dysfunction under hypothermic conditions. 20 Platelet counts decreased continuously past the end of cooling up to 24 hours after rewarming and had only slightly recovered 48 hours later.
There are several case reports on acute pancreatic injury in accidental hypothermia. Pancreatitis of varying severity, ranging from subclinical pancreatitis with high serum amylase and lipase activities to hemorrhagic pancreatitis, has been observed. 12, 14, 35 In our study hypothermia led to a marked increase in serum lipase activity, in conjunction with signs of pancreatitis in four patients and transitory hyperglycemia in two patients seen on ultrasonography and CT scans. The exact pathogenetic mechanism of this pancreatic injury is not clear. Direct surface cooling of animal pancreas was effective in creating histological and laboratory pancreatitis. 24 In this study all pathological signs of pancreatitis were completely reversible after rewarming. Abdominal trauma as a potential reason for pancreatic injury was excluded. Therefore, the pathogenesis of pancreatitis is considered to be hypothermia related.
The Traumatic Coma Data Bank 15 reported a survival rate of 67% in all patients admitted to a hospital with the diagnosis of severe traumatic brain injury, excluding gunshot wounds. At the time of hospital discharge, only 7% of these patients could be classified with a "good recovery," whereas the remaining survivors had some degree of neurological disability. Considering these data on the one hand and the severity of injury in our patients on the other, we believe the outcome of our patients is encouraging.
Conclusions
In conclusion, we discovered the most beneficial cerebral effects as well as the potentially hazardous extracerebral effects of moderate hypothermia (32.5˚C-33.0˚C) applied for approximately 24 hours. It reduces cerebral oxygen consumption by approximately 45% and, thereby, improves the cerebral oxygen supply-demand relationship. Consequently, cerebral ischemia decreases, as demonstrated by the decline in CMRL. Hypothermia is effective in reducing intracranial hypertension. Important side effects are reduction of platelet counts, impairment of renal function, and pancreatitis. In our study, no patient was really endangered, and these side effects were reversible by rewarming. However, no one knows what would happen if patients were cooled for a longer period. According to its beneficial cerebral effects, moderate hypothermia treatment may improve the outcome of severely head-injured patients, especially if potential side effects are detected immediately. To ensure patients' safety, additional monitoring equipment and personnel are mandatory. Before moderate hypothermia is routinely used as a treatment modality in this group of patients, further prospective randomized clinical studies on a larger patient population are needed.
